Peer Review History
| Original SubmissionMay 12, 2025 |
|---|
|
Dear Dr. AYTAR, Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process. Please submit your revised manuscript by Nov 17 2025 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org . When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.
If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols . Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols . We look forward to receiving your revised manuscript. Kind regards, José M. Alvarez-Suarez Academic Editor PLOS ONE Journal Requirements: When submitting your revision, we need you to address these additional requirements. 1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and 2. In your Methods section, please provide additional information regarding the permits you obtained for the work. Please ensure you have included the full name of the authority that approved the field site access and, if no permits were required, a brief statement explaining why. 3. Thank you for stating the following financial disclosure: “This project was supported by Researchers Supporting Project Number (RSP-2026R7) King Saud University, Riyadh, Saudi Arabia.” Please state what role the funders took in the study. If the funders had no role, please state: "The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript." If this statement is not correct you must amend it as needed. Please include this amended Role of Funder statement in your cover letter; we will change the online submission form on your behalf. 4. In the online submission form, you indicated that “All data generated or analyzed during this study are available from the corresponding author upon reasonable request.” All PLOS journals now require all data underlying the findings described in their manuscript to be freely available to other researchers, either 1. In a public repository, 2. Within the manuscript itself, or 3. Uploaded as supplementary information. This policy applies to all data except where public deposition would breach compliance with the protocol approved by your research ethics board. If your data cannot be made publicly available for ethical or legal reasons (e.g., public availability would compromise patient privacy), please explain your reasons on resubmission and your exemption request will be escalated for approval. 5. If the reviewer comments include a recommendation to cite specific previously published works, please review and evaluate these publications to determine whether they are relevant and should be cited. There is no requirement to cite these works unless the editor has indicated otherwise. Additional Editor Comments: The manuscript entitled “Assessing the chemical profile and biological potentials of Tamarix smyrnensis flower extracts using different solvents by in vitro, in silico, and network methodologies” presents an interesting and integrative study that combines in vitro antioxidant assays, phytochemical analysis by HPLC, in silico predictions of protein–compound interactions, and molecular docking studies. The research provides novel information on T. smyrnensis, a poorly studied species, and offers a chemical and bioactive profile of its flowers that could be useful for the scientific community. However, for the manuscript to be considered in PLOS ONE, certain methodological, interpretative, and formal aspects need to be strengthened. • Regarding originality, the study contributes novel data, but the introduction devotes excessive space to taxonomic and geographical distribution aspects of the species, to the detriment of the scientific justification and the identification of knowledge gaps. I recommend summarizing this part and placing greater emphasis on why T. smyrnensis flowers represent a suitable model for phytochemical and antioxidant studies. • The experimental design is clear; however, an important limitation is observed in the representativeness of the samples, as they come from a single locality and collection date. This reduces the possibility of generalizing the results and does not take into account intraspecific or seasonal variations. This is one of the main constraints regarding the potential reproducibility of the results presented here. It would be advisable to explicitly state this limitation and discuss it in the Results or Conclusions section. • With respect to the statistical analysis, the authors use only means, standard deviations, and correlations, which is appropriate as an initial description but insufficient to support comparisons between solvents or compounds. I suggest strengthening this section with significance tests (ANOVA, multiple comparisons, etc.) that would allow statistical validation of the reported differences. • The HPLC results show a detailed profile of phenolic and flavonoid compounds, although some values (for example, the catechin concentration in the methanolic extract) appear unusually high compared with previous literature. This should be carefully reviewed, either with an additional methodological explanation or, failing that, by moderating the conclusions. • The in silico analysis section (STITCH, STRING, and molecular docking) is technically solid but is interpreted in very general terms. Interactions with key proteins (COQ2, HMOX1, PTGS2, PON1) are mentioned, but a more critical analysis of what modulating these targets means in a physiological or pharmacological context is lacking. Moreover, it should be more clearly emphasized that these findings are predictions that require experimental in vivo or in vitro validation to be confirmed. • As for the discussion, there is a good effort to relate the findings to previous studies in other Tamarix species. However, at times the comparison is too extensive and detracts from the clarity of the central points of the study. I recommend prioritizing the discussion of the authors’ own results and using them as the basis for a reflection on the real therapeutic potential of the extracts, rather than for an extensive literature review. • The writing in English is understandable, but there are grammatical problems, repetitions, and long sentences that hinder fluent reading. I suggest professional language editing to improve clarity and precision. • The conclusions should end with a more critical reflection on the limitations of the study and guidance toward future steps (e.g., in vivo validation, toxicological studies, or specific pharmacological applications). In summary, the work is interesting, has an integrative methodological approach, and provides new results on a poorly studied species. However, it presents limitations in sample representativeness, statistical robustness, clarity in the interpretation of phytochemical values, and precision in the biological discussion. We strongly recommend that the authors address these points, which we consider of great importance for possible consideration in PLOS ONE. Therefore, I recommend major revision before this manuscript can be considered for publication in PLOS ONE. [Note: HTML markup is below. Please do not edit.] Reviewers' comments: Reviewer's Responses to Questions Comments to the Author 1. Is the manuscript technically sound, and do the data support the conclusions? Reviewer #1: Yes Reviewer #2: Yes ********** 2. Has the statistical analysis been performed appropriately and rigorously? -->?> Reviewer #1: Yes Reviewer #2: Yes ********** 3. Have the authors made all data underlying the findings in their manuscript fully available??> The PLOS Data policy Reviewer #1: Yes Reviewer #2: Yes ********** 4. Is the manuscript presented in an intelligible fashion and written in standard English??> Reviewer #1: Yes Reviewer #2: Yes ********** Reviewer #1: The manuscript presents a comprehensive and methodologically robust investigation into the phytochemical composition and antioxidant potential of Tamarix smyrnensis flower extracts using in vitro assays, HPLC analysis, in silico modeling, and network pharmacology. Integrating solvent-dependent extraction data with bioinformatics and molecular docking provides valuable insights into the bioactivity of key phenolic compounds such as chlorogenic acid and catechin. The experimental design is sound, and the data are presented and well-supported by the literature. However, the following minor concerns must be addressed to ensure that the manuscript is enriched: 1. The rationale for focusing on T. smyrnensis flowers should be more explicitly stated in the Introduction. While the species’ wide distribution is noted, it's unclear whether flowers have traditional medicinal use or are chemically distinct from other plant parts previously studied. 2. Reduce numeric data in the abstract and emphasize main findings and significance. 3. The choice of solvents is appropriate, but there is no yield comparison or extraction efficiency data provided. For example, including data like mg extract/g dry weight would contextualize the antioxidant data more meaningfully. 4. More detailed interpretation of biological pathways affected by COQ2, HMOX1, PTGS2, etc., would enhance the depth of discussion. 5. Include docking validation to support the reliability of the docking protocol. For example, redocking of native ligands or RMSD values. 6. Figures 3 and 4 do not look professional. Optimize them. For example, putting 3D and 2D side by side will enhance content presentation. 7. Discuss the protein-ligand interaction in the context of catalytically essential residues of the enzymes to rational the observed activity. For example, residues essential for COX-2 catalytic activity have been discussed in https://doi.org/10.1002/slct.202402286. A similar discussion can be added for the other proteins. Reviewer #2: The present manuscript provides a comprehensive study on the chemical composition and antioxidant potential of Tamarix smyrnensis flower extracts using different solvents. The integration of in vitro antioxidant assays with in silico prediction and docking provides a valuable framework for elucidating the therapeutic potential of plant-derived phenolics. The work demonstrates robust methodological framework, incorporating contemporaneous techniques such as STITCH, STRING, and molecular docking. The phytochemical profiling of the samples was conducted via HPLC, a method which allows for the specific interpretation of the antioxidant activities of the compounds. Comparison of the activities of different extracts of the same species prepared using different solvents was useful to increase the utilisation of the sample. however, it is suggested that the following minor corrections be made. - It is suggested that the importance of data obtained from in silico studies should be better emphasised. - Although it is stated that the flower of the plant is used in most of the study, it is stated that the aerial parts are used in a few places. this situation should be corrected. (Line 214) - Materials and methods section: - Line 124: The word ‘plants’ should be deleted. - Line 130: instead of "methanolic extracts", "all extracts used" should be written. - Line 221: "All other extracts showed lower values" this sentence should be rewritten. - In table 2 the spelling of compounds should be revised. (For example Qercetin, Hesperitin) ********** what does this mean? ). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy Reviewer #1: Yes: ABDULLAHI IBRAHIM UBA Reviewer #2: No ********** [NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.] While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/ . PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org . Please note that Supporting Information files do not need this step. |
| Revision 1 |
|
Dear Dr. AYTAR, Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process. Please submit your revised manuscript by Dec 14 2025 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org . When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.
If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols . Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols . We look forward to receiving your revised manuscript. Kind regards, José M. Alvarez-Suarez Academic Editor PLOS ONE Journal Requirements: If the reviewer comments include a recommendation to cite specific previously published works, please review and evaluate these publications to determine whether they are relevant and should be cited. There is no requirement to cite these works unless the editor has indicated otherwise. Please review your reference list to ensure that it is complete and correct. If you have cited papers that have been retracted, please include the rationale for doing so in the manuscript text, or remove these references and replace them with relevant current references. Any changes to the reference list should be mentioned in the rebuttal letter that accompanies your revised manuscript. If you need to cite a retracted article, indicate the article’s retracted status in the References list and also include a citation and full reference for the retraction notice. [Note: HTML markup is below. Please do not edit.] Reviewers' comments: Reviewer's Responses to Questions Comments to the Author Reviewer #1: (No Response) Reviewer #2: All comments have been addressed ********** 2. Is the manuscript technically sound, and do the data support the conclusions??> Reviewer #1: Partly Reviewer #2: Yes ********** 3. Has the statistical analysis been performed appropriately and rigorously? -->?> Reviewer #1: Yes Reviewer #2: Yes ********** 4. Have the authors made all data underlying the findings in their manuscript fully available??> The PLOS Data policy Reviewer #1: No Reviewer #2: Yes ********** 5. Is the manuscript presented in an intelligible fashion and written in standard English??> Reviewer #1: Yes Reviewer #2: Yes ********** Reviewer #1: The revised manuscript entitled “Assessing the chemical profile and biological potentials of Tamarix smyrnensis flower extracts using different solvents by in vitro, in silico, and network methodologies” presents an improved and more coherent version of the earlier submission. The authors have addressed several previous concerns, particularly regarding statistical treatment, clarity of sampling rationale, and focus of the discussion. The integration of in vitro antioxidant assays with in silico and network analyses provides a multidimensional view of T. smyrnensis’ bioactivity. However, the following deficiencies remain and could be effectively addressed: 1) The introduction has been condensed and now provides a clearer rationale for studying T. smyrnensis flowers. However, the research gap could still be more explicitly defined, particularly how this study advances beyond previous Tamarix phytochemical reports or similar solvent-comparison studies 2) The HPLC quantification lacks validation parameters (linearity, LOD, LOQ, recovery, repeatability), which are essential for confirming quantitative accuracy. 3) Docking lacks validation steps. For example, RMSD or redocking of co-crystallized ligands. 4) Enhance discussion by linking compound levels quantitatively to antioxidant outcomes. 5) Minor language polishing for conciseness and clarity Reviewer #2: The authors have addressed my suggestions with great diligence and have implemented all recommended revisions comprehensively. The importance of the in-silico studies has been better emphasized, and related comments have been clarified. Consistency regarding the plant part used has been ensured, eliminating any confusion between the flower and aerial parts throughout the manuscript. In the Materials and Methods section, language and terminology errors have been corrected, the word “plants” has been removed, “methanolic extracts” has been replaced with “all extracts used,” and certain sentences (e.g., “All other extracts showed lower values”) have been rewritten for clarity. Additionally, spelling errors in Table 2 (e.g., Quercetin, Hesperitin) have been corrected. These revisions have strengthened the methodological integrity and overall academic quality of the study. ********** what does this mean? ). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy Reviewer #1: No Reviewer #2: No ********** [NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.] To ensure your figures meet our technical requirements, please review our figure guidelines: https://journals.plos.org/plosone/s/figures You may also use PLOS’s free figure tool, NAAS, to help you prepare publication quality figures: https://journals.plos.org/plosone/s/figures#loc-tools-for-figure-preparation. NAAS will assess whether your figures meet our technical requirements by comparing each figure against our figure specifications. |
| Revision 2 |
|
Assessing the chemical profile and biological potentials of Tamarix smyrnensis flower extracts using different solvents by in vitro, in silico, and network methodologies PONE-D-25-25656R2 Dear Dr. AYTAR, We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements. Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication. An invoice will be generated when your article is formally accepted. Please note, if your institution has a publishing partnership with PLOS and your article meets the relevant criteria, all or part of your publication costs will be covered. Please make sure your user information is up-to-date by logging into Editorial Manager at Editorial Manager® and clicking the ‘Update My Information' link at the top of the page. For questions related to billing, please contact billing support . If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org. Kind regards, José M. Alvarez-Suarez Academic Editor PLOS ONE Additional Editor Comments (optional): Reviewers' comments: Reviewer's Responses to Questions Comments to the Author Reviewer #1: All comments have been addressed ********** 2. Is the manuscript technically sound, and do the data support the conclusions??> Reviewer #1: Yes ********** 3. Has the statistical analysis been performed appropriately and rigorously? -->?> Reviewer #1: I Don't Know ********** 4. Have the authors made all data underlying the findings in their manuscript fully available??> The PLOS Data policy Reviewer #1: Yes ********** 5. Is the manuscript presented in an intelligible fashion and written in standard English??> Reviewer #1: Yes ********** Reviewer #1: All concerns have been addressed and the manuscript is now sound. The manuscript can be accepted for publication in PLOS One ********** what does this mean? ). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy Reviewer #1: No ********** |
| Formally Accepted |
|
PONE-D-25-25656R2 PLOS ONE Dear Dr. AYTAR, I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now being handed over to our production team. At this stage, our production department will prepare your paper for publication. This includes ensuring the following: * All references, tables, and figures are properly cited * All relevant supporting information is included in the manuscript submission, * There are no issues that prevent the paper from being properly typeset You will receive further instructions from the production team, including instructions on how to review your proof when it is ready. Please keep in mind that we are working through a large volume of accepted articles, so please give us a few days to review your paper and let you know the next and final steps. Lastly, if your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org. You will receive an invoice from PLOS for your publication fee after your manuscript has reached the completed accept phase. If you receive an email requesting payment before acceptance or for any other service, this may be a phishing scheme. Learn how to identify phishing emails and protect your accounts at https://explore.plos.org/phishing. If we can help with anything else, please email us at customercare@plos.org. Thank you for submitting your work to PLOS ONE and supporting open access. Kind regards, PLOS ONE Editorial Office Staff on behalf of Professor José M. Alvarez-Suarez Academic Editor PLOS ONE |
Open letter on the publication of peer review reports
PLOS recognizes the benefits of transparency in the peer review process. Therefore, we enable the publication of all of the content of peer review and author responses alongside final, published articles. Reviewers remain anonymous, unless they choose to reveal their names.
We encourage other journals to join us in this initiative. We hope that our action inspires the community, including researchers, research funders, and research institutions, to recognize the benefits of published peer review reports for all parts of the research system.
Learn more at ASAPbio .